help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nisato, R. E.
Right arrow Articles by Pepper, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nisato, R. E.
Right arrow Articles by Pepper, M. S.
(American Journal of Pathology. 2004;165:11-24.)
© 2004 American Society for Investigative Pathology


Technical Advance

Generation and Characterization of Telomerase-Transfected Human Lymphatic Endothelial Cells with an Extended Life Span

Riccardo E. Nisato*, Jillian A. Harrison*, Raphaele Buser*, Lelio Orci*, Chris Rinsch{dagger}, Roberto Montesano*, Philippe Dupraz{dagger} and Michael S. Pepper*

From the Department of Morphology,* University Medical Center, Geneva; and Isotis SA,{dagger} Lausanne, Switzerland

The study of lymphatic endothelial cells and lymphangiogenesis has, in the past, been hampered by the lack of lymphatic endothelial-specific markers. The recent discovery of several such markers has permitted the isolation of lymphatic endothelial cells (LECs) from human skin. However, cell numbers are limited and purity is variable with the different isolation procedures. To overcome these problems, we have transfected human dermal microvascular endothelial cells (HDMVECs) with a retrovirus containing the coding region of human telomerase reverse transcriptase (hTERT), and have produced a cell line, hTERT-HDLEC, with an extended lifespan. hTERT-HDLEC exhibit a typical cobblestone morphology when grown in culture, are contact-inhibited, and express endothelial cell-specific markers. hTERT-HDLEC also express the recognized lymphatic markers, Prox-1, LYVE-1 and podoplanin, as well as integrin {alpha}9, but do not express CD34. They also form tube-like structures in three-dimensional collagen gels when stimulated with vascular endothelial growth factors -A and -C. Based on these currently recognized criteria, these cells are LEC. Surprisingly, we also found that the widely studied HMEC-1 cell line expresses recognized lymphatic markers; however, these cells are also CD34-positive. In summary, the ectopic expression of hTERT increases the life span of LECs and does not affect their capacity to form tube-like structures in a collagen matrix. The production and characterization of hTERT-HDLEC will facilitate the study of the properties of lymphatic endothelium in vitro.





This article has been cited by other articles:


Home page
J. Immunol.Home page
S. J. van Vliet, L. C. Paessens, V. C. M. Broks-van den Berg, T. B. H. Geijtenbeek, and Y. van Kooyk
The C-Type Lectin Macrophage Galactose-Type Lectin Impedes Migration of Immature APCs
J. Immunol., September 1, 2008; 181(5): 3148 - 3155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Pegu, S. Qin, B. A. Fallert Junecko, R. E. Nisato, M. S. Pepper, and T. A. Reinhart
Human Lymphatic Endothelial Cells Express Multiple Functional TLRs
J. Immunol., March 1, 2008; 180(5): 3399 - 3405.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Zecchini, M. Bianchi, N. Colombo, R. Fasani, G. Goisis, C. Casadio, G. Viale, J. Liu, M. Herlyn, A. K. Godwin, et al.
The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium
Cancer Res., February 15, 2008; 68(4): 1110 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Johnson, R. Prevo, S. Clasper, and D. G. Jackson
Inflammation-induced Uptake and Degradation of the Lymphatic Endothelial Hyaluronan Receptor LYVE-1
J. Biol. Chem., November 16, 2007; 282(46): 33671 - 33680.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. A. Johnson, S. Clasper, A. P. Holt, P. F. Lalor, D. Baban, and D. G. Jackson
An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium
J. Exp. Med., November 27, 2006; 203(12): 2763 - 2777.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M-A Brundler, J A Harrison, B de Saussure, M de Perrot, and M S Pepper
Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma
J. Clin. Pathol., February 1, 2006; 59(2): 191 - 195.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bjorndahl, R. Cao, L. J. Nissen, S. Clasper, L. A. Johnson, Y. Xue, Z. Zhou, D. Jackson, A. Jon Hansen, and Y. Cao
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo
PNAS, October 25, 2005; 102(43): 15593 - 15598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Prevo, S. Banerji, J. Ni, and D. G. Jackson
Rapid Plasma Membrane-Endosomal Trafficking of the Lymph Node Sinus and High Endothelial Venule Scavenger Receptor/Homing Receptor Stabilin-1 (Feel-1/Clever-1)
J. Biol. Chem., December 10, 2004; 279(50): 52580 - 52592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.